Latest Period
Q1 2026
Security Snapshot
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) Institutional Ownership
CUSIP: 87990A106
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
103
Shares (Excl. Options)
54,305,766
Price
$0.69
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- TNYA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 54,305,766
- Total 13F value
- $37,512,767
- Portfolio coverage rank
- 0%
- Share change
- -15,210,655
- Value change
- -$10,937,925
- Number of holders
- 103
- Shares outstanding
- 213,832,909
- SEC-reported price per share
- $1.00
- Insider filing price
- $1.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 87990A106.
- 103 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 97 to 103 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $48,758,847 to $37,512,767.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 103 institutions filings for Q1 2026.
Security key
87990A106
Latest holder period
Q1 2026
13F holders
103
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
TNYA full holder history
Tenaya Therapeutics, Inc. SEC filings
Tenaya Therapeutics, Inc. company facts
Tenaya Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87990A106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
TNYA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Woodline Partners LP | 5% | -26% | $6,120,000 | +$2,097,006 | 9,000,000 | +52% | Woodline Partners LP | 30 Jun 2025 |
| Empery Asset Management, LP | 5% | -50% | $5,641,468 | -$293,106 | 8,296,276 | -4.9% | Empery Asset Management, LP | 30 Jun 2025 |
| Casdin Capital, LLC | 4.3% | $3,231,826 | 6,732,971 | Casdin Capital, LLC | 04 Mar 2025 | |||
| BlackRock, Inc. | 1.7% | -71% | $1,670,287 | -$1,566,919 | 2,732,800 | -48% | BlackRock, Inc. | 30 Jun 2025 |
| JPMORGAN CHASE & CO | 2.8% | -53% | $1,096,279 | -$1,378,097 | 2,283,914 | -56% | JPMORGAN CHASE & CO. | 28 Feb 2025 |
As of 31 Mar 2026, 103 institutional investors reported holding 54,305,766 shares of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA). This represents 25% of the company’s total 213,832,909 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 8,482,288 | 0% | 0% | $5,869,743 |
| MILLENNIUM MANAGEMENT LLC | 2.6% | 5,456,666 | +18% | 0% | $3,778,196 |
| Empery Asset Management, LP | 2% | 4,286,933 | -21% | 3.6% | $2,968,272 |
| CITADEL ADVISORS LLC | 2% | 4,200,000 | 0% | 0% | $2,908,080 |
| RENAISSANCE TECHNOLOGIES LLC | 1.7% | 3,713,761 | +101% | 0% | $2,571,408 |
| BlackRock, Inc. | 1.7% | 3,703,955 | -6.2% | 0% | $2,564,618 |
| MARSHALL WACE, LLP | 1.3% | 2,705,390 | +92% | 0% | $1,866,719 |
| Kalehua Capital Management LLC | 0.94% | 2,000,000 | 0% | 0.98% | $1,384,800 |
| Burkehill Global Management, LP | 0.94% | 2,000,000 | 0% | 0.07% | $1,384,800 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.73% | 1,559,939 | +31% | 0% | $1,080,800 |
| ADAR1 Capital Management, LLC | 0.71% | 1,507,800 | +0.17% | 0.06% | $1,044,001 |
| TWO SIGMA INVESTMENTS, LP | 0.6% | 1,280,390 | +1.1% | 0% | $886,542 |
| JANE STREET GROUP, LLC | 0.55% | 1,180,081 | +74% | 0% | $817,089 |
| GSA CAPITAL PARTNERS LLP | 0.5% | 1,072,911 | -27% | 0.05% | $743,000 |
| Euclidean Capital LLC | 0.47% | 1,015,705 | 0% | 0.18% | $703,274 |
| VANGUARD FIDUCIARY TRUST CO | 0.47% | 1,015,702 | 0% | 0% | $702,866 |
| Raiffeisen Bank International AG | 0.47% | 1,000,000 | +11% | 0.01% | $620,000 |
| Alphabet Inc. | 0.43% | 915,705 | 0% | 0.02% | $631,836 |
| Mirador Capital Partners LP | 0.41% | 886,917 | +52% | 0.09% | $614,101 |
| STATE STREET CORP | 0.33% | 708,721 | +59% | 0% | $490,718 |
| UBS Group AG | 0.31% | 665,180 | +15% | 0% | $460,305 |
| StepStone Group LP | 0.22% | 462,163 | 0% | 0.15% | $318,892 |
| Casdin Capital, LLC | 0.17% | 361,969 | 0% | 0.02% | $250,627 |
| Squarepoint Ops LLC | 0.16% | 348,268 | 0% | $241,141 | |
| NORTHERN TRUST CORP | 0.15% | 310,654 | +29% | 0% | $215,097 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q1 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 54,305,766 | $37,512,767 | -$10,937,925 | $0.69 | 103 |
| 2025 Q4 | 68,535,823 | $48,758,847 | +$17,052,952 | $0.71 | 97 |
| 2025 Q3 | 34,529,364 | $55,547,747 | +$5,381,496 | $1.62 | 89 |
| 2025 Q2 | 31,571,002 | $19,291,816 | -$9,941,570 | $0.61 | 87 |
| 2025 Q1 | 48,166,604 | $27,453,207 | +$1,982,469 | $0.57 | 104 |
| 2024 Q4 | 43,606,618 | $62,359,118 | -$25,849,595 | $1.43 | 83 |
| 2024 Q3 | 57,630,896 | $111,228,656 | +$67,017 | $1.93 | 91 |
| 2024 Q2 | 57,076,933 | $176,981,415 | +$2,253,617 | $3.10 | 94 |
| 2024 Q1 | 56,023,483 | $292,935,438 | +$51,188,426 | $5.23 | 89 |
| 2023 Q4 | 46,629,309 | $151,075,893 | -$9,232,276 | $3.24 | 73 |
| 2023 Q3 | 49,741,215 | $126,838,955 | -$3,313,935 | $2.55 | 77 |
| 2023 Q2 | 47,651,950 | $279,717,125 | +$15,890,634 | $5.87 | 79 |
| 2023 Q1 | 45,028,141 | $128,326,772 | -$2,290,501 | $2.85 | 65 |
| 2022 Q4 | 47,128,809 | $94,724,321 | +$22,977,493 | $2.01 | 67 |
| 2022 Q3 | 35,221,703 | $102,151,001 | -$12,249,474 | $2.90 | 67 |
| 2022 Q2 | 37,062,342 | $208,638,443 | -$1,855,716 | $5.63 | 47 |
| 2022 Q1 | 37,349,150 | $439,920,087 | +$23,331,598 | $11.78 | 50 |
| 2021 Q4 | 35,354,543 | $667,600,957 | +$18,069,398 | $18.95 | 46 |
| 2021 Q3 | 24,450,664 | $499,284,447 | +$499,284,447 | $20.65 | 44 |